Michael C. McQueeny and Charles J. Messina, Firm Cannabis Law Practice Co-Chairs, gave their views in an article entitled “CBD oil is being added to products all the time. Should the government start regulating sales?” on NJ.com. The article is about hemp-derived cannabidiol (better known as CBD), which manufacturers are adding to numerous consumer products and the U.S. Food and Drug Administration has held a hearing on to determine whether or how to regulate the ingredient.
Mr. McQueeny said in the article: “Finally, the federal government is taking meaningful steps to get a grasp on the industry. Regulation takes time and in the interim there is a huge flood of products in the marketplace.” He and Mr. Messina said that there are many other issues for the FDA to address including 1) setting standard doses of CBD, 2) looking at whether warnings need to be placed on labels, 3) establishing expiration dates for products, and 4) ensuring that manufacturing processes for cannabidiol products do not contain THC, which is the psychoactive compound in marijuana.
To read the full article, please click here.